Experimental models of brain ischemia: A review of techniques, magnetic resonance imaging, and investigational cell-based therapies

Frontiers in Neurology

Volumn 5 FEB, Issue , 2014, Pages

  Canazza, Alessandra ^a   Minati, Ludovico ^a,b   Boffano, Carlo ^a   Parati, Eugenio ^a   Binks, Sophie ^b,c  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^c Worthing Hospital   (United Kingdom)

Author keywords

Animal models; Brain ischemia; Brain stroke; Magnetic resonance imaging; Middle cerebral artery occlusion; Neuro reparative therapies; Stem cells

Indexed keywords

ENDOTHELIN 1;

ADIPOSE DERIVED STEM CELL; ANEURYSM CLIP; BRAIN ISCHEMIA; CELL TRACKING; CEREBROVASCULAR ACCIDENT; COGNITION; DIFFUSION WEIGHTED IMAGING; DISEASE MODEL; ELECTROCOAGULATION; EMBRYONIC STEM CELL; EXPERIMENTAL BEHAVIORAL TEST; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; INTRALUMINAL SUTURE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEURAL STEM CELL TRANSPLANTATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; RESTING STATE NETWORK; REVIEW; STEM CELL NICHE; SUBVENTRICULAR ZONE; THROMBOEMBOLISM;

EID: 84895533661     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00019     Document Type: Review

References (172)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet (2008) 371(9624):1612-23. doi:10.1016/S0140-6736(08)60694-7.
2. El Khoury R, Jung R, Nanda A, Sila C, Abraham MG, Castonguay AC, et al. Overview of key factors in improving access to acute stroke care. Neurology (2012) 79(13 Suppl 1):S26-34. doi:10.1212/WNL.0b013e3182695a2a.
3. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 375(9727):1695-703. doi:10.1016/S0140-6736(10)60491-6.
4. IST-3 Collaborative Group Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet (2012) 379(9834):2352-63. doi:10.1016/S0140-6736(12)60768-5.
5. Dirnagl U. Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab (2006) 26(12):1465-78. doi:10.1038/sj.jcbfm.9600298.
6. Chen JR, Cheng GY, Sheu CC, Tseng GF, Wang TJ, Huang YS. Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke. J Anat (2008) 213:249-58. doi:10.1111/j.1469-7580.2008.00948.x.
7. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol (2009) 8(5):491-500. doi:10.1016/S1474-4422(09)70061-4.
8. Lees JS, Sena ES, Egan KJ, Antonic A, Koblar SA, Howells DW, et al. Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis. Int J Stroke (2012) 7(7):582-8. doi:10.1111/j.1747-4949.2012.00797.x.
9. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 8(3):e1000344. doi:10.1371/journal.pbio.1000344.
10. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke (1989) 20(1):84-9. doi:10.1161/01.STR.20.1.84.
11. Macrae I. New models of focal cerebral ischaemia. Br J Clin Pharmacol (1992) 34(4):302-8. doi:10.1111/j.1365-2125.1992.tb05634.x.
12. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature (1975) 155(5506):332-4. doi:10.1038/255332a0.
13. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 1(1):53-60. doi:10.1038/jcbfm.1981.6.
14. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 2. Regional cerebral blood flow determined by [14C] iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab (1981) 1(1):61-9. doi:10.1038/jcbfm.1981.7.
15. Coyle P. Middle cerebral artery occlusion in the young rat. Stroke (1982) 13(6):855-9. doi:10.1161/01.STR.13.6.855.
16. Boyko M, Zlotnik A, Gruenbaum BF, Gruenbaum SE, Ohayon S, Goldsmith T, et al. An experimental model of focal ischemia using an internal carotid artery approach. J Neurosci Methods (2010) 193(2):246-53. doi:10.1016/j.jneumeth.2010.08.026.
17. Kanemitsu H, Nakagomi T, Tamura A, Tsuchiya T, Kono G, Sano K. Differences in the extent of primary ischemic damage between middle cerebral artery coagulation and intraluminal occlusion models. J Cereb Blood Flow Metab (2002) 22(10):1196-204. doi:10.1097/00004647-200210000-00007.
18. Xi GM, Wang HQ, He GH, Huang CF, Wei GY. Evaluation of murine models of permanent focal cerebral ischemia. Chin Med J (Engl) (2004) 117(3):389-94.
19. Liu F, McCullough LD. Middle cerebral artery occlusion model in rodents: methods and potential pitfalls. J Biomed Biotechnol (2011) 2011:464701. doi:10.1155/2011/464701.
20. Howells DW, Porritt MJ, Rewell SJ, O'Collins V, Sena ES, van der Worp HB, et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischaemia. J Cereb Blood Flow Metab (2010) 30(8):1412-31. doi:10.1038/jcbfm.2010.66.
21. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J. Endothelin induced reductions in cerebral blood flow: dose-dependency, time course and neuropathological consequences. J Cereb Blood Flow Metab (1993) 13(2):276-84. doi:10.1038/jcbfm.1993.34.
22. Sharkey J, Ritchie IM, Kelly PA. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1993) 13(5):865-71. doi:10.1038/jcbfm.1993.108.
23. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav (2007) 87(1):179-97. doi:10.1016/j.pbb.2007.04.015.
24. Bacigaluppi M, Comi G, Hermann DM. Animal models of ischemic stroke. Part two: modelling cerebral ischemia. Open Neurol J (2010) 4:34-8. doi:10.2174/1874205X01004020034.
25. Soylu H, Zhang D, Buist R, Martin M, Albensi BC, Parkinson FE. Intracortical injection of endothelin-1 induces cortical infarcts in mice: effect of neuronal expression of an adenosine transporter. Exp Transl Stroke Med (2012) 4(1):4. doi:10.1186/2040-7378-4-4.
26. Morancho A, García-Bonilla L, Barceló V, Giralt D, Campos-Martorell M, Garcia S, et al. A new method for focal transient cerebral ischaemia by distal compression of the middle cerebral artery. Neuropathol Appl Neurobiol (2012) 38(6):617-27. doi:10.1111/j.1365-2990.2012.01252.x.
27. Krafft PR, Bailey EL, Lekic T, Rolland WB, Altahy O, Tang J, et al. Etiology of stroke and choice of models. Int J Stroke (2012) 7(5):398-406. doi:10.1111/j.1747-4949.2012.00838.x.
28. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. I. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn Stroke J (1986) 8:1-8. doi:10.3995/jstroke.8.1.
29. Kamii H, Kinouchi H, Sharp FR, Koistinaho J, Epstein CJ, Chan PH. Prolonged expression of hsp70 mRNA following transient focal cerebral ischemia in transgenic mice overexpressing CuZn-superoxide dismutase. J Cereb Blood Flow Metab (1994) 14(3):478-86. doi:10.1038/jcbfm.1994.59.
30. Lo EH, Hara H, Rogowska J, Trocha M, Pierce AR, Huang PL, et al. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke (1996) 27(8):1381-5. doi:10.1161/01.STR.27.8.1381.
31. Chiang T, Messing RO, Chou WH. Mouse model of middle cerebral artery occlusion. J Vis Exp (2011) 48:ii:2761. doi:10.3791/2761.
32. Hofmeijer J, Kappelle LK, Algra A, Amelink GJ, van Gijn J, van der Worp HB. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol (2009) 8(4):326-33. doi:10.1016/S1474-4422(09)70047-X.
33. Kuraoka M, Furuta T, Matsuwaki T, Omatsu T, Ishii Y, Kyuwa S, et al. Direct experimental occlusion of the distal middle cerebral artery induces high reproducibility of brain ischemia in mice. Exp Anim (2009) 58(1):19-29. doi:10.1538/expanim.58.19.
34. Overgaard K. Thrombolytic therapy in experimental embolic stroke. Cerebrovasc Brain Metab Rev (1994) 6(3):257-86.
35. Brinker G, Franke C, Hoehn M, Uhlenkuken U, Hossmann KA. Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport (1999) 10(16):3269-72. doi:10.1097/00001756-199911080-00004.
36. Zhang L, Zhang ZG, Zhang C, Zhang RL, Chopp M. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke (2004) 35(12):2890-5. doi:10.1161/01.STR.0000147963.68238.da.
37. Papadopoulos SM, Chandler WF, Salamat MS, Topol EJ, Sackellares JC. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg (1987) 67(3):394-8. doi:10.3171/jns.1987.67.3.0394.
38. Takano K, Carano RA, Tatlisumak T, Meiler M, Sotak CH, Kleinert HD, et al. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging. Neurology (1998) 50(4):870-5. doi:10.1212/WNL.50.4.870.
39. Rapp JH, Pan XM, Yu B, Swanson RA, Higashida RT, Simpson P, et al. Cerebral ischemia and infarction from atheroemboli <100 μm in size. Stroke (2003) 34(8):1976-80. doi:10.1161/01.STR.0000083400.80296.38.
40. Mayzel-Oreg O, Omae T, Kazemi M, Li F, Fisher M, Cohen Y, et al. Microsphere-induced embolic stroke: an MRI study. Magn Reson Med (2004) 51(6):1232-8. doi:10.1002/mrm.20100.
41. Zhu L, Hoffman A, Wintermark M, Pan X, Tu R, Rapp JH. Do microemboli reach the brain penetrating arteries? J Surg Res (2012) 176(2):679-83. doi:10.1016/j.jss.2011.09.059.
42. Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, et al. Mouse model of in situ thromboembolic stroke and reperfusion. Stroke (2007) 38(10):2771-8. doi:10.1161/STROKEAHA.107.487520.
43. Niessen F, Hilger T, Hoehn M, Hossmann KA. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke (2003) 34(8):2019-34. doi:10.1161/01.STR.0000080941.73934.30.
44. Kurosawa M, Fuxe K, Hallstrom A, Goiny M, Cintra A, Ungerstedt U. Responses of blood flow, extracellular lactate, and dopamine in the striatum to intrastriatal injection of endothelin-1 in anesthetized rats. J Cardiovasc Pharmacol (1991) 17(Suppl 7):S340-2. doi:10.1097/00005344-199100177-00097.
45. Soleman S, Yip P, Leasure JL, Moon L. Sustained sensorimotor impairments after endothelin-1 induced focal cerebral ischemia (stroke) in aged rats. Exp Neurol (2010) 222(1):13-24. doi:10.1016/j.expneurol.2009.11.007.
46. Bogaert L, Scheller D, Moonen J, Sarre S, Smolders I, Ebinger G, et al. Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model for focal cerebral ischemia. Brain Res (2000) 887(2):266-75. doi:10.1016/S0006-8993(00)02959-0.
47. Horie N, Maag AL, Hamilton SA, Shichinohe H, Bliss TM, Steinberg GK. Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 173(2):286-90. doi:10.1016/j.jneumeth.2008.06.013.
48. Macrae IM. Pre-clinical stroke research-advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol (2011) 164(4):1062-78. doi:10.1111/j.1476-5381.2011.01398.x.
49. Shigeno T, Teasdale GM, McCulloch J, Graham DI. Recirculation model following MCA occlusion in rats. Cerebral blood flow, cerebrovascular permeability, and brain edema. J Neurosurg (1985) 63(2):272-7. doi:10.3171/jns.1985.63.2.0272.
50. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest (1999) 104(11):1613-20. doi:10.1172/JCI8218.
51. Stem Cell Therapies as an Emerging Paradigm in Stroke Participants. Stem cell therapies as an emerging paradigm in stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke (2009) 40(2):510-5. doi:10.1161/STROKEAHA.108.526863.
52. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke (2011) 42(3):825-9. doi:10.1161/STROKEAHA.110.601914.
53. Chan P. Role of oxidants in ischemic brain damage. Stroke (1996) 27:1124-9. doi:10.1161/01.STR.27.6.1124.
54. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (1994) 265:1883-5. doi:10.1126/science.7522345.
55. Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, et al. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci (2005) 25(9):2366-75. doi:10.1523/JNEUROSCI.5071-04.2005.
56. Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx (2005) 2(3):396-409. doi:10.1602/neurorx.2.3.396.
57. Kitigawa K, Matsumoto M, Yang G, Mabuchi T, Yagita Y, Hori M, et al. Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture occlusion in mice: evaluation of the patency of the posterior communicating artery. J Cereb Blood Flow Metab (1998) 18(5):570-9. doi:10.1097/00004647-199805000-00012.
58. Kelly S, McCulloch J, Horsburgh K. Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. Brain Res (2001) 914(1-2):185-95. doi:10.1016/S0006-8993(01)02801-3.
59. Hemmen TM, Lyden PD. Induced hypothermia for acute stroke. Stroke (2007) 38(2 Suppl):794-9. doi:10.1161/01.STR.0000247920.15708.fa.
60. Kim Y, Busto R, Dietrich WD, Kraydieh S, Ginsberg MD. Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia. Stroke (2007) 27(12):2274-80. doi:10.1161/01.STR.27.12.2274.
61. Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke (1999) 30(12):2752-8. doi:10.1161/01.STR.30.12.2752.
62. Traystman RJ. Animal models of focal and global cerebral ischemia. ILAR J (2003) 44:85-95. doi:10.1093/ilar.44.2.85.
63. Rink C, Christoforidis G, Abduljalil A, Kontzialis M, Bergdall V, Roy S, et al. Minimally invasive neuroradiologic model of preclinical transient middle cerebral artery occlusion in canines. Proc Natla Acad Sci USA (2008) 105(37):14100-5. doi:10.1073/pnas.0806678105.
64. Wagner KR, Xi G, Hua Y, Kleinholz M, de Courten-Myers GM, Myers RE, et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke (1996) 27(3):490-7. doi:10.1161/01.STR.27.3.490.
65. Imai H, Konno K, Nakamura M, Shimizu T, Kubota C, Seki K, et al. A new model of focal cerebral ischemia in the miniature pig. J Neurosurg (2006) 104(2 Suppl):123-32. doi:10.3171/ped.2006.104.2.123.
66. Kang BT, Lee JH, Jung DI, Park C, Gu SH, Jeon HW, et al. Canine model of ischemic stroke with permanent middle cerebral artery occlusion: clinical and histopathological findings. J Vet Sci (2007) 8(4):369-76. doi:10.4142/jvs.2007.8.4.369.
67. Boltze J, Förschler A, Nitzsche B, Waldmin D, Hoffmann A, Boltze CM, et al. Permanent middle cerebral artery occlusion in sheep: a novel large animal model of focal cerebral ischemia. J Cereb Blood Flow Metab (2008) 28(12):1951-64. doi:10.1038/jcbfm.2008.89.
68. Liggins JT, Yoo AJ, Mishra NK, Wheeler HM, Straka M, Leslie-Mazwi TM, et al. A score based on age and DWI volume predicts poor outcome following endovascular treatment for acute ischaemic stroke. Int J Stroke (2013). doi:10.1111/ijs.12207.
69. Di Filippo M, Tozzi A, Costa C, Belcastro V, Tantucci M, Picconi B, et al. Plasticity and repair in the post-ischemic brain. Neuropharmacology (2008) 55(3):353-62. doi:10.1016/j.neuropharm.2008.01.012.
70. Freret T, Schumann-Bard P, Boulouard M, Bouet V. On the importance of long-term functional assessment after stroke to improve translation from bench to bedside. Exp Trans Stroke Med (2011) 3:6. doi:10.1186/2040-7378-3-6.
71. Zarruk JG, Garcia-Yebenes I, Romera VG, Ballesteros I, Moraga A, Cuartero MI, et al. Neurological tests for functional outcome assessment in rodent models of ischaemic stroke. Rev Neurol (2011) 53(10):607-18.
72. Schallert T. Behavioural tests for preclinical intervention assessment. NeuroRx (2006) 3(4):497-504. doi:10.1016/j.nurx.2006.08.001.
73. Balkaya M, Kröber JM, Rex A, Endres M. Assessing post-stroke behaviour in mouse models of focal ischemia. J Cereb Blood Flow Metab (2013) 33(3):330-8. doi:10.1038/jcbfm.2012.185.
74. Shi Y, Sun D. Neurobehavioral assessments of focal cerebral ischemia: sensorimotor deficit. In: Jun C, Xiao-Ming X, Zao CX, John HZ editors. Animal Models of Acute Neurological Injuries II. New York: Humana Press (2012). p. 149-56.
75. Balkaya M, Kröber J, Gertz K, Peruzzaro S, Endres M. Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods (2013) 213(2):179-87. doi:10.1016/j.jneumeth.2012.12.021.
76. Wang D, Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res (1990) 533(1):78-82. doi:10.1016/0006-8993(90)91798-L.
77. Shi Y, Sun D. Neurobehavioral assessments of focal cerebral ischemia: cognitive deficit. In: Jun C, Xiao-Ming X, Zao CX, John HZ editors. Animal Models of Acute Neurological Injuries II. New York: Humana Press (2012). p. 157-62.
78. Block F. Global ischemia and behavioural deficits. Prog Neurobiol (1999) 58(3):279-95. doi:10.1016/S0301-0082(98)00085-9.
79. Lindner MD, Gribkoff VK, Donlan NA, Jones TA. Long-lasting functional disabilities in middle-aged rats with small cerebral infarcts. J Neurosci (2003) 23(34):10913-22.
80. Prakash R, Li W, Qu Z, Johnson MA, Fagan SC, Ergul A. Vascularization pattern after ischemic stroke is different in control versus diabetic rats. Stroke (2013) 44(10):2875-82. doi:10.1161/STROKEAHA.113.001660.
81. Nedelmann M, Wilhelm-Schwenkmezger T, Alessandri B, Heimann A, Schneider F, Eicke BM, et al. Cerebral embolic ischemia in rats: correlation of stroke severity and functional deficit as important outcome parameter. Brain Res (2007) 1130(1):188-96. doi:10.1016/j.brainres.2006.10.087.
82. Mestriner GB, Miguel PM, Bagatini PB, Saur L, Boisserand LS, Baptista PP, et al. Behavior outcome after ischemic and hemorrhagic stroke, with similar brain damage, in rats. Behav Brain Res (2013) 244:82-9. doi:10.1016/j.bbr.2013.02.001.
83. Nudo RJ, Wise BM, SiFuentes F, Milliken GW. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science (1996) 272(5269):1791-4. doi:10.1126/science.272.5269.1791.
84. Marshall JW, Ridley RM, Baker HF, Hall LD, Carpenter TA, Wood NI. Serial MRI, functional recovery, and long-term infarct maturation in a non-human primate model of stroke. Brain Res Bull (2003) 61(6):577-85. doi:10.1016/S0361-9230(03)00214-4.
85. Clarkson AN, López-Valdés HE, Overman JJ, Charles AC, Brennan KC, Carmichael ST. Multimodal examination of structural and functional remapping in the mouse photothrombotic stroke model. J Cereb Blood Flow Metab (2013) 33(5):716-23. doi:10.1038/jcbfm.2013.7.
86. Duong TQ, Fisher M. Applications of diffusion/perfusion magnetic resonance imaging in experimental and clinical aspects of stroke. Curr Atheroscler Rep (2004) 6(4):267-73. doi:10.1007/s11883-004-0057-y.
87. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol (1994) 36:557-65. doi:10.1002/ana.410360404.
88. Back T. Pathophysiology of the ischemic penumbra-revision of a concept. Cell Mol Neurobiol (1998) 18(6):621-38. doi:10.1023/A:1020265701407.
89. Sobesky J. Refining the mismatch concept in acute stroke: lessons learned from PET and MRI. J Cereb Blood Flow Metab (2012) 32(7):1416-25. doi:10.1038/jcbfm.2012.54.
90. Olivot JM, Marks MP. Magnetic resonance imaging in the evaluation of acute stroke. Top Magn Reson Imaging (2008) 19(5):225-30. doi:10.1097/RMR.0b013e3181aaf37c.
91. Kloska SP, Wintermark M, Engelhorn T, Fiebach JB. Acute stroke magnetic resonance imaging: current status and future perspective. Neuroradiology (2010) 52(3):189-201. doi:10.1007/s00234-009-0637-1.
92. Moseley ME, Cohen Y, Mintorovitch J, Chileuitt L, Shimizu H, Kucharczyk J, et al. Early detection of regional cerebral ischemia in cats comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med (1990) 14:330-46. doi:10.1002/mrm.1910140218.
93. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab (1998) 18:583-609. doi:10.1097/00004647-199806000-00001.
94. Davis D, Ulatowski J, Eleff S, Izuta M, Mori S, Shungu D, et al. Rapid monitoring of changes in water diffusion coefficients during reversible ischemia in cat and rat brain. Magn Reson Med (1994) 31(4):454-60. doi:10.1002/mrm.1910310416.
95. Mintorovitch J, Moseley ME, Chileuitt L, Shimizu H, Cohen Y, Weinstein PR. Comparison of diffusion-and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med (1991) 18(1):39-50. doi:10.1002/mrm.1910180106.
96. Klatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol (1987) 72(3):236-9. doi:10.1007/BF00691095.
97. Bardutzky J, Shen Q, Bouley J, Sotak CH, Duong TQ, Fisher M. Perfusion and diffusion imaging in acute focal cerebral ischemia: temporal vs. spatial resolution. Brain Res (2005) 1043(1-2):155-62. doi:10.1016/j.brainres.2005.02.073.
98. Bardutzky J, Shen Q, Henninger N, Bouley J, Duong TQ, Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke (2005) 36(9):2000-5. doi:10.1161/01.STR.0000177486.85508.4d.
99. Hoehn-Berlage M, Norris DG, Kohno K, Mies G, Leibfritz D, Hossmann KA. Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances. J Cereb Blood Flow Metab (1995) 15(6):1002-11. doi:10.1038/jcbfm.1995.126.
100. Srinivasan A, Goyal M, Al Azri F, Lum C. State-of-the-art imaging of acute stroke. Radiographics (2006) 26(Suppl 1):S75-95. doi:10.1148/rg.26si065501.
101. Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P, et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke (2007) 38(12):3158-64. doi:10.1161/STROKEAHA.107.483842.
102. Grandin CB, Duprez TP, Smith AM, Mataigne F, Peeters A, Oppenheim C, et al. Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke (2001) 32(5):1147-53. doi:10.1161/01.STR.32.5.1147.
103. Provenzale JM, Shah K, Patel U, McCrory DC. Systematic review of CT and MR perfusion imaging for assessment of acute cerebrovascular disease. AJNR Am J Neuroradiol (2008) 29:1476-82. doi:10.3174/ajnr.A1161.
104. Wardlaw JM. Neuroimaging in acute ischaemic stroke: insights into unanswered questions of pathophysiology. Intern Med (2010) 267(2):172-90. doi:10.1111/j.1365-2796.2009.02200.x.
105. Heiss WD, Sobesky J. Comparison of PET and DW/PW-MRI in acute ischemic stroke. Keio J Med (2008) 57(3):125-31. doi:10.2302/kjm.57.125.
106. Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J Cereb Blood Flow Metab (1998) 18(7):758-67. doi:10.1097/00004647-199807000-00007.
107. Meng X, Fisher M, Shen Q, Sotak CH, Duong TQ. Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol (2004) 55(2):207-12. doi:10.1002/ana.10803.
108. Ward NS, Brown MM, Thompson AJ, Frackowiak RS. Neural correlates of motor recovery after stroke: a longitudinal fMRI study. Brain (2003) 126:2476-96. doi:10.1093/brain/awg245.
109. Saur D, Lange R, Baumgaertner A, Schraknepper V, Willmes K, Rijntjes M, et al. Dynamics of language reorganization after stroke. Brain (2006) 129:1371-84. doi:10.1093/brain/awl090.
110. Dijkhuizen RM, Ren J, Mandeville JB, Wu O, Ozdag FM, Moskowitz MA, et al. Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc Natl Acad Sci U S A (2001) 98(22):12766-71. doi:10.1073/pnas.231235598.
111. Dijkhuizen RM, Singhal AB, Mandeville JB, Wu O, Halpern EF, Finklestein SP, et al. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci (2003) 23(2):510-7.
112. Dijkhuizen RM, van der Marel K, Otte WM, Hoff EI, van der Zijden JP, van der Toorn A, et al. Functional MRI and diffusion tensor imaging of brain reorganization after experimental stroke. Transl Stroke Res (2012) 3(1):36-43. doi:10.1007/s12975-011-0143-8.
113. van Meer MP, Otte WM, van der Marel K, Nijboer CH, Kavelaars A, van der Sprenkel JW, et al. Extent of bilateral neuronal network reorganization and functional recovery in relation to stroke severity. J Neurosci (2012) 32(13):4495-507. doi:10.1523/JNEUROSCI.3662-11.2012.
114. Ramos-Cabrer P, Justicia C, Wiedermann D, Hoehn M. Stem cell mediation of functional recovery after stroke in the rat. PLoS One (2010) 5(9):e12779. doi:10.1371/journal.pone.0012779.
115. Sicard KM, Henninger N, Fisher M, Duong TQ, Ferris CF. Long-term changes of functional MRI-based brain function, behavioral status, and histopathology after transient focal cerebral ischemia in rats. Stroke (2006) 37(10):2593-600. doi:10.1161/01.STR.0000239667.15532.c1.
116. Weber R, Ramos-Cabrer P, Justicia C, Wiedermann D, Strecker C, Sprenger C, et al. Early prediction of functional recovery after experimental stroke: functional magnetic resonance imaging, electrophysiology, and behavioral testing in rats. J Neurosci (2008) 28(5):1022-9. doi:10.1523/JNEUROSCI.4147-07.2008.
117. Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med (1995) 34(4):537-41. doi:10.1002/mrm.1910340409.
118. Rosazza C, Minati L. Resting-state brain networks: literature review and clinical applications. Neurol Sci (2011) 32(5):773-85. doi:10.1007/s10072-011-0636-y.
119. Jonckers E, Van Audekerke J, De Visscher G, Van der Linden A, Verhoye M. Functional connectivity fMRI of the rodent brain: comparison of functional connectivity networks in rat and mouse. PLoS One (2011) 6(4):e18876. doi:10.1371/journal.pone.0018876.
120. Hoehn M, Wiedermann D, Justicia C, Ramos-Cabrer P, Kruttwig K, Farr T, et al. Cell tracking using magnetic resonance imaging. J Physiol (2007) 584(Pt 1):25-30. doi:10.1113/jphysiol.2007.139451.
121. Küstermann E, Himmelreich U, Kandal K, Geelen T, Ketkar A, Wiedermann D, et al. Efficient stem cell labeling for MRI studies. Contrast Media Mol Imaging (2008) 3(1):27-37. doi:10.1002/cmmi.229.
122. Boehm-Sturm P, Mengler L, Wecker S, Hoehn M, Kallur T. In vivo tracking of human neural stem cells with 19F magnetic resonance imaging. PLoS One (2011) 6(12):e29040. doi:10.1371/journal.pone.0029040.
123. Srinivas M, Boehm-Sturm P, Figdor CG, de Vries IJ, Hoehn M. Labeling cells for in vivo tracking using (19)F MRI. Biomaterials (2012) 33(34):8830-40. doi:10.1016/j.biomaterials.2012.08.048.
124. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 3(4):343-55. doi:10.1002/wnan.140.
125. Manley NC, Steinberg GK. Tracking stem cells for cellular therapy in stroke. Curr Pharm Des (2012) 18(25):3685-93. doi:10.2174/138161212802002643.
126. Harms C, Datwyler AL, Wiekhorst F, Trahms L, Lindquist R, Schellenberger E, et al. Certain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to stroke. J Cereb Blood Flow Metab (2013) 33(5):e1-9. doi:10.1038/jcbfm.2013.22.
127. Wang PC, Shan L. Essential elements to consider for MRI cell tracking studies with iron oxide-based labeling agents. J Basic Clin Med (2012) 1(1):1-6.
128. Taylor A, Wilson KM, Murray P, Fernig DG, Lévy R. Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet? Chem Soc Rev (2012) 41(7):2707-17. doi:10.1039/c2cs35031a.
129. Adamczak J, Hoehn M. In vivo imaging of cell transplants in experimental ischemia. Prog Brain Res (2012) 201:55-78. doi:10.1016/B978-0-444-59544-7.00004-4.
130. Sinden JD, Muir KW. Stem cells in stroke treatment: the promise and the challenges. Int J Stroke (2012) 7(5):426-34. doi:10.1111/j.1747-4949.2012.00840.x.
131. Smith HK, Gavins FN. The potential of stem cell therapy for stroke: is PISCES the sign? FASEB J (2012) 26(6):2239-52. doi:10.1096/fj.11-195719.
132. Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol (2005) 18(1):59-64. doi:10.1097/00019052-200502000-00012.
133. Dharmasaroja P. Bone marrow-derived mesenchymal stem cells for the treatment of ischemic stroke. J Clin Neurosci (2009) 16(1):12-20. doi:10.1016/j.jocn.2008.05.006.
134. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 7(2):211-28. doi:10.1089/107632701300062859.
135. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res (2007) 100(9):1249-60. doi:10.1161/01.RES.0000265074.83288.09.
136. Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature (2002) 418(6893):50-6. doi:10.1038/nature00900.
137. Bjorklund LM, Sánchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A (2002) 99(4):2344-9. doi:10.1073/pnas.022438099.
138. Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol (2002) 20(11):1103-10. doi:10.1038/nbt750.
139. Hoehn M, Nicolay K, Franke C, van der Sanden B. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging (2001) 14(5):491-509. doi:10.1002/jmri.1213.
140. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 8:963-70. doi:10.1038/nm747.
141. Parent JM, Vexler ZS, Gong C, Derugin N, Ferriero DM. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann Neurol (2002) 52:802-13. doi:10.1002/ana.10393.
142. Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, Darsalia V, et al. Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells (2006) 24(3):739-47. doi:10.1634/stemcells.2005-0281.
143. Leker RR, Soldner F, Velasco I, Gavin DK, Androutsellis-Theotokis A, McKay RD. Long-lasting regeneration after ischemia in the cerebral cortex. Stroke (2007) 38(1):153-61. doi:10.1161/01.STR.0000252156.65953.a9.
144. Kokaia Z, Thored P, Arvidsson A, Lindvall O. Regulation of stroke induced neurogenesis in adult brain-recent scientific progress. Cereb Cortex (2006) 16(Suppl 1):i162-7. doi:10.1093/cercor/bhj174.
145. Monfils MH, Driscoll I, Kamitakahara H, Wilson B, Flynn C, Teskey GC, et al. FGF-2-induced cell proliferation stimulates anatomical, neurophysiological and functional recovery from neonatal motor cortex injury. Eur J Neurosci (2006) 24(3):739-49. doi:10.1111/j.1460-9568.2006.04939.x.
146. Kuhn HG, Winkler J, Kempermann G, Thal LJ, Gage FG. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 17(15):5820-9.
147. Kilic E, ElAli A, Kilic U, Guo Z, Ugur M, Uslu U, et al. Role of Nogo-A in neuronal survival in the reperfused ischemic brain. J Cereb Blood Flow Metab (2010) 30(5):969-84. doi:10.1038/jcbfm.2009.268.
148. Rolando C, Parolisi R, Boda E, Schwab ME, Rossi F, Buffo A. Distinct roles of nogo-a and nogo receptor 1 in the homeostatic regulation of adult neural stem cell function and neuroblast migration. J Neurosci (2012) 32(49):17788-99. doi:10.1523/JNEUROSCI.3142-12.2012.
149. Wang X, Mao X, Xie L, Sun F, Greenberg DA, Jin K. Conditional depletion of neurogenesis inhibits long-term recovery after experimental stroke in mice. PLoS One (2012) 7(6):e38932. doi:10.1371/journal.pone.0038932.
150. Bjorklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res (1979) 177(3):555-60. doi:10.1016/0006-8993(79)90472-4.
151. Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science (1979) 204(4393):643-7. doi:10.1126/science.571147.
152. Burns TC, Verfaillie CM, Low WC. Stem cells for ischemic brain injury: a critical review. J Comp Neurol (2009) 515(1):125-44. doi:10.1002/cne.22038.
153. Scheibe F, Gladow N, Mergenthaler P, Tucker AH, Meisel A, Prockop DJ, et al. Nonviral gene delivery of erythropoietin by mesenchymal stromal cells. Gene Ther (2012) 19(5):550-60. doi:10.1038/gt.2011.139.
154. Fujiwara Y, Tanaka N, Ishida O, Fujimoto Y, Murakami T, Kajihara H, et al. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci Lett (2004) 366(3):287-91. doi:10.1016/j.neulet.2004.05.080.
155. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Del Bo R, Fortunato F, et al. Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX (ssea-1) +/CXCR4+ stem cells. FASEB J (2005) 19(13):1860-2. doi:10.1096/fj.05-4170fje.
156. Johnston RE, Dillon-Carter O, Freed WJ, Borlongan CV. Trophic factor secreting kidney cell lines: in vitro characterization and functional effects following transplantation in ischemic rats. Brain Res (2001) 900(2):268-76. doi:10.1016/S0006-8993(01)02327-7.
157. Bhasin A, Srivastava MV, Kumaran SS, Mohanty S, Bhatia R, Bose S, et al. Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra (2011) 1(1):93-104. doi:10.1159/000333381.
158. Pendharkar AV, Chua JY, Andres RH, Wang N, Gaeta X, Wang H, et al. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke (2010) 41(9):2064-70. doi:10.1161/STROKEAHA.109.575993.
159. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science (2000) 290(5497):1779-82. doi:10.1126/science.290.5497.1779.
160. Cogle CR, Yachnis AT, Laywell ED, Zander DS, Wingard JR, Steindler DA, et al. Bone marrow transdifferentiation in brain after transplantation: a retrospective study. Lancet (2004) 363(9419):1432-7. doi:10.1016/S0140-6736(04)16102-3.
161. Zhang XM, Du F, Yang D, Yu CJ, Huang XN, Liu W, et al. Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke. BMC Neurosci (2010) 11:138. doi:10.1186/1471-2202-11-138.
162. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 32(4):1005-11. doi:10.1161/01.STR.32.4.1005.
163. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol (2002) 1(2):92-100. doi:10.1016/S1474-4422(02)00040-6.
164. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, et al. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res (2010) 88(5):1017-25. doi:10.1002/jnr.22279.
165. Tsai LK, Wang Z, Munasinghe J, Leng Y, Leeds P, Chuang DM. Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke (2011) 42(10):2932-9. doi:10.1161/STROKEAHA.110.612788.
166. Goldmacher GV, Nasser R, Lee DY, Yigit S, Rosenwasser R, Iacovitti L. Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model. PLoS One (2013) 8(3):e60049. doi:10.1371/journal.pone.0060049.
167. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, et al. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther (2011) 2(5):38. doi:10.1186/scrt79.
168. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy (2011) 13(6):675-85. doi:10.3109/14653249.2010.549122.
169. Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol (2006) 24(4):150-4. doi:10.1016/j.tibtech.2006.01.010.
170. Li H, Fan X, Kovi RC, Jo Y, Moquin B, Konz R, et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res (2007) 67(22):10889-98. doi:10.1158/0008-5472.CAN-07-2665.
171. Misra V, Ritchie MM, Stone LL, Low WC, Janardhan V. Stem cell therapy in ischemic stroke. Role of IV and intra-arterial therapy. Neurology (2012) 79(13 Suppl 1):S207-12. doi:10.1212/WNL.0b013e31826959d2.
172. Yang YC, Liu BS, Shen CC, Lin CH, Chiao MT, Cheng HC. Transplantation of adipose tissue-derived stem cells for treatment of focal cerebral ischemia. Curr Neurovasc Res (2011) 8(1):1-13.